Inventia Recalls Chlorthalidone Tablets Due to Failed Dissolution Specifications
Inventia Healthcare Limited is recalling 13,567 bottles of Chlorthalidone 25 mg tablets because they failed dissolution specifications. The recall is nationwide.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, which typically involves a situation that might cause temporary or medically reversible adverse health consequences. The hazard is a failure to meet dissolution specifications, which is a quality control issue rather than a direct contamination or acute safety defect like a structural failure or known pathogen.
Plain-English summary
Inventia Healthcare Limited is recalling 13,567 bottles of Chlorthalidone Tablets, USP, 25 mg. The affected product is identified by Batch # RISA24002 with an expiration date of 04/2027. The recall was initiated because the product failed to meet dissolution specifications.
The recalled medication is a prescription-only diuretic distributed nationwide in the United States. Chlorthalidone is used to treat high blood pressure and fluid retention. The specific NDC for the recalled 100-tablet bottles is 64980-599-01.
Consumers who have this specific batch of medication should stop using it and contact their healthcare provider or pharmacist for guidance on obtaining a replacement. Patients should not discontinue their blood pressure medication without consulting a medical professional.
The recalled product
- Product
- CHLORTHALIDONE (CHLORTHALIDONE)
- Brand
- CHLORTHALIDONE
- Manufacturer
- Inventia Healthcare Limited
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 13,567
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Batch # RISA24002
- Exp Date: 04/2027
UPCs (3)
- 0364980599108
- 0364980599016
- 0364980600019
Distribution
Distributed nationwide across the United States.
Related recalls
Same brand · CHLORTHALIDONE
- ModerateChlorthalidone 25mg tablets failed dissolution specifications in two batches
FDA (Drugs) · 2026-06-24
- ModerateChlorthalidone Tablets Recalled Due to Failed Dissolution Specifications
FDA (Drugs) · 2025-06-18
- ModerateChlorthalidone Tablets Recalled for Temperature Storage Deviations
FDA (Drugs) · 2024-01-03
- ModerateChlorthalidone Tablets Recalled for Foreign Matter Contamination
FDA (Drugs) · 2022-02-23
Same hazard · failed dissolution
See all →- SevereGolden State Medical Supply Recalls Prasugrel Tablets for Failed Dissolution
FDA (Drugs) · 2026-09-09
- ModerateMylan Recalls Prasugrel Tablets for Failed Dissolution and Stability Testing
FDA (Drugs) · 2026-09-09
- ModerateNovartis Recalls Diovan Valsartan Tablets Due to Failed Dissolution Specifications
FDA (Drugs) · 2026-08-19
- LowSupernus Recalls Trokendi XR Capsules for Failed Dissolution Specifications
FDA (Drugs) · 2026-07-29
- HighLannett niacin extended-release tablets failed dissolution specifications during stability
FDA (Drugs) · 2026-06-10